Follow the CellaVision AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, CellaVision AB has published 11 insider filings. Market capitalisation: €3.5bn. The latest transaction was filed on 12 June 2026 (Purchase). Among the most active insiders: christer Fåhraeus. All data is accessible without an account.
11
Insider Decl.
n/a
Thresholds
€2m
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CellaVision AB Buy (bullish), based on 3 analysts. Average price target: SEK 175.67.
22Σ signal
Buys €2mn/a Sells
Fundamental score
Ranked 6,145 of 29,053 companies
66.1
score / 100
Value
48
Quality
85
FCF yld2.9%
Earn yld3.9%
EV/EBITDA17.0x
ROE15%
Gross mgn68%
Net mgn20%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CellaVision AB is a company focused on developing image analysis solutions for medical diagnostics. It is listed on the Stockholm Stock Exchange (XSTO).